A Novel Risk Prediction Model for Checkpoint Inhibitor–Related Autoimmune Toxicities'
This project is a Federally funded project awarded to Dr. Jesse Keller by the Department of Defense.
This project's main aims are to describe rates of autoimmune toxicities within a real-world patient dataset across multiple tumor types and to develop a risk prediction model for grade 3-4 immune related adverse events in patients receiving immunotherapy.
Principal Investigator: Dr. Jesse Keller
This project is in the data analysis stages.
This study was funded through the Foundation by the Department of Defense (DOD)
This project's main aims are to describe rates of autoimmune toxicities within a real-world patient dataset across multiple tumor types and to develop a risk prediction model for grade 3-4 immune related adverse events in patients receiving immunotherapy.
Principal Investigator: Dr. Jesse Keller
This project is in the data analysis stages.
This study was funded through the Foundation by the Department of Defense (DOD)